NASH Alliance
  • Home
  • About
    • What is NASH?
    • About NASH Alliance
  • Resources
    • NASH Prevention
    • News
    • Publications
    • Additional Information
  • Events
  • Contact
Select Page
Simultaneous MR quantification of hepatic fat content

Simultaneous MR quantification of hepatic fat content

by ltsiwpadmin | Jul 5, 2017 | Overview & Epidemiology, Publications

Abstract Non-alcoholic steatohepatitis (NASH) is characterized at histology by steatosis, hepatocyte ballooning and inflammatory infiltrates, with or without fibrosis. Although diamagnetic material in fibrosis and inflammation can be detected with quantitative...
New treatments in non-alcoholic fatty liver disease

New treatments in non-alcoholic fatty liver disease

by ltsiwpadmin | Jul 4, 2017 | Diagnostics & Therapeutic Advancements, Publications

Abstract BACKGROUND Non-alcoholic fatty liver disease is the fastest growing cause of liver disease in the Western world, yet there is no approved pharmacotherapy. While lifestyle modifications remain the mainstay of treatment, only a proportion of individuals are...
Next Entries »

Recent Posts

  • Emerging cancer trends among young adults in the USA: analysis of a population-based cancer registry
  • About Danielle P. Turnipseed, J.D., M.H.S.A., M.P.P.
  • About Billy Wynne, J.D.
  • About Barret Thornhill, J.D.
  • Fatty liver disease strikes Latino children like a ‘silent tsunami’

Recent Comments

    Archives

    • October 2019
    • September 2019
    • July 2019
    • June 2019
    • April 2019
    • December 2018
    • October 2018
    • July 2017
    • June 2017
    • May 2017

    Categories

    • Diagnostics & Therapeutic Advancements
    • News
    • Overview & Epidemiology
    • Policy & Public Affairs
    • Prevention & Management
    • Publications
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    NASH Alliance

    info@NASHalliance.org

    Follow us on twitter